Resistin mediates the hepatic stellate cell phenotype

World Journal of Gastroenterology

Volumn 19, Issue 28, 2013, Pages 4475-4485

  Dong, Zhi Xia ^a,b   Su, Lin ^b   Brymora, Joanne ^b   Bird, Claire ^b   Xie, Qing ^a   George, Jacob ^b   Wang, Jian Hua ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Hepatic stellate cell; Kupffer cell; Liver fibrosis; Monocyte chemotactic protein 1; Resistin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RECOMBINANT PROTEIN; RESISTIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BILE DUCT LIGATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOBLOTTING; KUPFFER CELL; LIVER FIBROSIS; MALE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL;

EID: 84880802812     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i28.4475     Document Type: Article

References (40)

1. Peng S, Plank LD, McCall JL, Gillanders LK, McIlroy K, Gane EJ. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr 2007; 85: 1257-1266 [PMID: 17490961]
2. Lin SY, Chen WY, Lee FY, Huang CJ, Sheu WH. Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF-alpha. Am J Physiol Endocrinol Metab 2005; 288: E493-E501 [PMID: 15522995 DOI: 10.1152/ajpendo. 00186.2004]
3. Petrides AS. Liver disease and diabetes mellitus. Diabetes Rev 1994; 2: 2-18
4. Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, McCaughan GW, George J. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology 2003; 125: 1695-1704 [PMID: 14724822 DOI: 10.1053/j.gastro.2003.08.032]
5. Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005; 42: 987-1000 [PMID: 16250043 DOI: 10.1002/ hep.20920]
6. Wang J, Leclercq I, Brymora JM, Xu N, Ramezani-Moghadam M, London RM, Brigstock D, George J. Kupffer cells mediate leptin-induced liver fibrosis. Gastroenterology 2009; 137: 713-723 [PMID: 19375424 DOI: 10.1053/j.gastro.2009.04.011]
7. Wang J, Brymora J, George J. Roles of adipokines in liver injury and fibrosis. Expert Rev Gastroenterol Hepatol 2008; 2: 47-57 [PMID: 19072370 DOI: 10.1586/17474124.2.1.47]
8. Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, Lang T, Fukuda T, Yamashina S, Kitamura T, Sato N. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 2002; 122: 1399-1410 [PMID: 11984526 DOI: 10.1053/gast.2002.32995]
9. Kamada Y, Tamura S, Kiso S, Matsumoto H, Saji Y, Yoshida Y, Fukui K, Maeda N, Nishizawa H, Nagaretani H, Okamoto Y, Kihara S, Miyagawa J, Shinomura Y, Funahashi T, Matsuzawa Y. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 2003; 125: 1796-1807 [PMID: 14724832 DOI: 10.1053/ j.gastro.2003.08.029]
10. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312 [PMID: 11201732 DOI: 10.1038/35053000]
11. Qatanani M, Szwergold NR, Greaves DR, Ahima RS, Lazar MA. Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. J Clin Invest 2009; 119: 531-539 [PMID: 19188682 DOI: 10.1172/JCI37273]
12. Muse ED, Lam TK, Scherer PE, Rossetti L. Hypothalamic resistin induces hepatic insulin resistance. J Clin Invest 2007; 117: 1670-1678 [PMID: 17525801 DOI: 10.1172/JCI30440]
13. Pravenec M, Kazdová L, Landa V, Zidek V, Mlejnek P, Jansa P, Wang J, Qi N, Kurtz TW. Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J Biol Chem 2003; 278: 45209-45215 [PMID: 12944409 DOI: 10.1074/jbc. M304869200]
14. Yagmur E, Trautwein C, Gressner AM, Tacke F. Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases. Am J Gastroenterol 2006; 101: 1244-1252 [PMID: 16771945 DOI: 10.1111/j.1572-0241.2006.00543.x]
15. Bahr MJ, Ockenga J, Böker KH, Manns MP, Tietge UJ. Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance. Am J Physiol Endocrinol Metab 2006; 291: E199-E206 [PMID: 16478779 DOI: 10.1152/ ajpendo.00291.2005]
16. Tsochatzis E, Papatheodoridis GV, Hadziyannis E, Georgiou A, Kafiri G, Tiniakos DG, Manesis EK, Archimandritis AJ. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. Scand J Gastroenterol 2008; 43: 1128-1136 [PMID: 18609175 DOI: 10.1080/00365520802085387]
17. Kakizaki S, Sohara N, Yamazaki Y, Horiguchi N, Kanda D, Kabeya K, Katakai K, Sato K, Takagi H, Mori M. Elevated plasma resistin concentrations in patients with liver cirrhosis. J Gastroenterol Hepatol 2008; 23: 73-77 [PMID: 18171344 DOI: 10.1111/j.1440-1746.2006.04757.x]
18. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med 2004; 255: 439-447 [PMID: 15049878]
19. Lin SY, Sheu WH, Chen WY, Lee FY, Huang CJ. Stimulated resistin expression in white adipose of rats with bile duct ligation-induced liver cirrhosis: relationship to cirrhotic hyperinsulinemia and increased tumor necrosis factor-alpha. Mol Cell Endocrinol 2005; 232: 1-8 [PMID: 15737463 DOI: 10.1016/j.mce.2005.01.006]
20. Bertolani C, Sancho-Bru P, Failli P, Bataller R, Aleffi S, DeFranco R, Mazzinghi B, Romagnani P, Milani S, Ginés P, Colmenero J, Parola M, Gelmini S, Tarquini R, Laffi G, Pinzani M, Marra F. Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am J Pathol 2006; 169: 2042-2053 [PMID: 17148667 DOI: 10.2353/ajpath. 2006.060081]
21. Szalowska E, Elferink MG, Hoek A, Groothuis GM, Vonk RJ. Resistin is more abundant in liver than adipose tissue and is not up-regulated by lipopolysaccharide. J Clin Endocrinol Metab 2009; 94: 3051-3057 [PMID: 19454585 DOI: 10.1210/jc.2008-2787]
22. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005; 174: 5789-5795 [PMID: 15843582]
23. Son YM, Ahn SM, Kim GR, Moon YS, Kim SH, Park YM, Lee WK, Min TS, Han SH, Yun CH. Resistin enhances the expansion of regulatory T cells through modulation of dendritic cells. BMC Immunol 2010; 11: 33 [PMID: 20591185 DOI: 10.1186/1471-2172-11-33]
24. Teoh N, Dela Pena A, Farrell G. Hepatic ischemic preconditioning in mice is associated with activation of NF-kappaB, p38 kinase, and cell cycle entry. Hepatology 2002; 36: 94-102 [PMID: 12085353 DOI: 10.1053/jhep.2002.33134]
25. Liu Y, Brymora J, Zhang H, Smith B, Ramezani-Moghadam M, George J, Wang J. Leptin and acetaldehyde synergistically promotes αSMA expression in hepatic stellate cells by an interleukin 6-dependent mechanism. Alcohol Clin Exp Res 2011; 35: 921-928 [PMID: 21294755 DOI: 10.1111/ j.1530-0277.2010.01422.x]
26. Tsukamoto H. Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcohol Clin Exp Res 1999; 23: 911-916 [PMID: 10371413 DOI: 10.1111/j.1530-0277.1999.tb04202.x]
27. Farajzadeh-Sheikh A, Jolodar A, Ghaemmaghami S. Sequence characterization of cDNA sequence of encoding of an antimicrobial Peptide with no disulfide bridge from the Iranian mesobuthus eupeus venomous glands. Iran Red Crescent Med J 2013; 15: 36-41 [PMID: 23486842 DOI: 10.2174 /187152809789352230]
28. Seki E, de Minicis S, Inokuchi S, Taura K, Miyai K, van Rooijen N, Schwabe RF, Brenner DA. CCR2 promotes hepatic fibrosis in mice. Hepatology 2009; 50: 185-197 [PMID: 19441102 DOI: 10.1002/hep.22952]
29. Tharp K, Mattingly C. Whistleblowing. Plast Surg Nurs 1991; 11: 33-34 [PMID: 2034717 DOI: 10.1016/j.jhep.2009.10.035]
30. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-218 [PMID: 15690074 DOI: 10.1172/JCI200524282]
31. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655-1669 [PMID: 18471545 DOI: 10.1053/ j.gastro.2008.03.003]
32. Bissell DM, Roulot D, George J. Transforming growth factor beta and the liver. Hepatology 2001; 34: 859-867 [PMID: 11679955 DOI: 10.1053/jhep.2001.28457]
33. Kusminski CM, McTernan PG, Kumar S. Role of resistin in obesity, insulin resistance and Type II diabetes. Clin Sci (Lond) 2005; 109: 243-256 [PMID: 16104844 DOI: 10.1042/ CS20050078]
34. Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW, Scherer PE, Rossetti L. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 2004; 114: 232-239 [PMID: 15254590 DOI: 10.1172/JCI200421270]
35. Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun 2005; 334: 1092-1101 [PMID: 16039994 DOI: 10.1016/ j.bbrc.2005.06.202]
36. Edwards CR, Hindle AK, Latham PS, Fu SW, Brody FJ. Resistin expression correlates with steatohepatitis in morbidly obese patients. Surg Endosc 2013; 27: 1310-1314 [PMID: 23233000 DOI: 10.1007/s00464-012-2603-y]
37. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 2004; 1: e45 [PMID: 15578112 DOI: 10.1371/journal.pmed.0010045]
38. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S. Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001; 50: 2199-2202 [PMID: 11574398]
39. Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 2002; 530: 158-162 [PMID: 12387885 DOI: 10.1016/S0014-5793(02)03450-6]
40. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003; 309: 286-290 [PMID: 12951047 DOI: 10.1016/ j.bbrc.2003.07.003]